10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions

President Joe Biden touted the potential cost savings of Medicare's first-ever price negotiations for widely used prescription drugs on Tuesday as he struggles to convince Americans that he's improved their lives as he runs for reelection. The drugs include the blood thinner Eliquis, diabetes treatment Jardiance and eight other medications. The negotiation process was authorized under the Inflation Reduction Act, which Biden signed last year, capping decades of debate over whether the federal government should be allowed to haggle with pharmaceutical companies.